QUANTUMSCAPE CORP (QS) Fundamental Analysis & Valuation

NASDAQ:QSUS74767V1098

Current stock price

6.21 USD
-0.13 (-2.05%)
At close:
6.5003 USD
+0.29 (+4.67%)
After Hours:

This QS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. QS Profitability Analysis

1.1 Basic Checks

  • QS had negative earnings in the past year.
  • QS had a negative operating cash flow in the past year.
  • QS had negative earnings in each of the past 5 years.
  • QS had a negative operating cash flow in each of the past 5 years.
QS Yearly Net Income VS EBIT VS OCF VS FCFQS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -500M -1B -1.5B

1.2 Ratios

  • QS's Return On Assets of -33.26% is on the low side compared to the rest of the industry. QS is outperformed by 85.37% of its industry peers.
  • The Return On Equity of QS (-37.22%) is worse than 68.29% of its industry peers.
Industry RankSector Rank
ROA -33.26%
ROE -37.22%
ROIC N/A
ROA(3y)-33.01%
ROA(5y)-25.93%
ROE(3y)-37.25%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
QS Yearly ROA, ROE, ROICQS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • QS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QS Yearly Profit, Operating, Gross MarginsQS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

6

2. QS Health Analysis

2.1 Basic Checks

  • QS has more shares outstanding than it did 1 year ago.
  • QS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, QS has an improved debt to assets ratio.
QS Yearly Shares OutstandingQS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 200M 400M 600M
QS Yearly Total Debt VS Total AssetsQS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 12.06 indicates that QS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of QS (12.06) is better than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that QS is not too dependend on debt financing.
  • The Debt to Equity ratio of QS (0.02) is better than 80.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 12.06
ROIC/WACCN/A
WACCN/A
QS Yearly LT Debt VS Equity VS FCFQS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 15.95 indicates that QS has no problem at all paying its short term obligations.
  • QS has a Current ratio of 15.95. This is amongst the best in the industry. QS outperforms 100.00% of its industry peers.
  • QS has a Quick Ratio of 15.95. This indicates that QS is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 15.95, QS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.95
Quick Ratio 15.95
QS Yearly Current Assets VS Current LiabilitesQS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B

1

3. QS Growth Analysis

3.1 Past

  • QS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.15%, which is quite good.
EPS 1Y (TTM)19.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 29.25% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.22%
EPS Next 2Y7.93%
EPS Next 3Y18.47%
EPS Next 5Y29.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QS Yearly Revenue VS EstimatesQS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
QS Yearly EPS VS EstimatesQS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 -1 -1.5

0

4. QS Valuation Analysis

4.1 Price/Earnings Ratio

  • QS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year QS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QS Price Earnings VS Forward Price EarningsQS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QS Per share dataQS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as QS's earnings are expected to grow with 18.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.93%
EPS Next 3Y18.47%

0

5. QS Dividend Analysis

5.1 Amount

  • QS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

QS Fundamentals: All Metrics, Ratios and Statistics

QUANTUMSCAPE CORP

NASDAQ:QS (4/7/2026, 9:00:52 PM)

After market: 6.5003 +0.29 (+4.67%)

6.21

-0.13 (-2.05%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-11
Earnings (Next)04-29
Inst Owners36.86%
Inst Owner Change0%
Ins Owners1.7%
Ins Owner Change-2.38%
Market Cap3.80B
Revenue(TTM)N/A
Net Income(TTM)-435.05M
Analysts45.56
Price Target7.97 (28.34%)
Short Float %17.66%
Short Ratio6.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.57%
Min EPS beat(2)4.52%
Max EPS beat(2)12.62%
EPS beat(4)3
Avg EPS beat(4)4.71%
Min EPS beat(4)-1.22%
Max EPS beat(4)12.62%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)6
Avg EPS beat(12)0.92%
EPS beat(16)6
Avg EPS beat(16)-5.33%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-21.01%
EPS NQ rev (1m)-1.8%
EPS NQ rev (3m)4.25%
EPS NY rev (1m)6.31%
EPS NY rev (3m)6.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-14.87%
Revenue NY rev (3m)-14.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.25
P/tB 3.25
EV/EBITDA N/A
EPS(TTM)-0.76
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0
BVpS1.91
TBVpS1.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.26%
ROE -37.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-33.01%
ROA(5y)-25.93%
ROE(3y)-37.25%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.95
Quick Ratio 15.95
Altman-Z 12.06
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)121.42%
Cap/Depr(5y)412.1%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.73%
EPS Next Y9.22%
EPS Next 2Y7.93%
EPS Next 3Y18.47%
EPS Next 5Y29.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.36%
EBIT Next 3Y14.94%
EBIT Next 5Y34.77%
FCF growth 1Y17.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.69%
OCF growth 3YN/A
OCF growth 5YN/A

QUANTUMSCAPE CORP / QS Fundamental Analysis FAQ

What is the fundamental rating for QS stock?

ChartMill assigns a fundamental rating of 2 / 10 to QS.


What is the valuation status of QUANTUMSCAPE CORP (QS) stock?

ChartMill assigns a valuation rating of 0 / 10 to QUANTUMSCAPE CORP (QS). This can be considered as Overvalued.


Can you provide the profitability details for QUANTUMSCAPE CORP?

QUANTUMSCAPE CORP (QS) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for QS stock?

The Earnings per Share (EPS) of QUANTUMSCAPE CORP (QS) is expected to grow by 9.22% in the next year.